Summary
Hepatocellular carcinoma (HCC) is the most common primary liver cancer with incidences doubled over the past two decades due to increasing risk factors. Despite surveillance, the majority of HCC cases are diagnosed at advanced stages that can be treated only using (Transarterial chemoembolization) TACE, or systemic therapy. TACE failure can occur to 60% of patients receiving the procedure, with subsequent financial and emotional burden. Radiomics have emerged as a new tool capable of predicting tumor response to TACE from pre-procedural CT study.This retrospectively acquired data collection includes pre- and post-procedure CT imaging studies of 105 confirmed HCC patients who underwent TACE between 2002 and 2012 with an available treatment outcome, in the form of time-to-progression and overall survival. Baseline imaging includes multiphasic contrast-enhanced CT with no image artifacts (e.g. surgical clip) and was obtained 1-12 weeks (average 3 weeks) prior to the first TACE session. Semiautomatic segmentation of liver, tumor, and blood vessels created using AMIRA was manually clinically curated. These segmentations of each pre-procedural CT study were done for the purpose of algorithm training for prediction and automatic liver tumor segmentation, and are provided here (NIfTI converted to DICOM-SEG format).
Acknowledgements
We would like to acknowledge the individuals and institutions that have provided data for this collection:
The University of Texas MD Anderson Cancer Center, Departments of Imaging Physics, Body Imaging, Gastrointestinal Oncology, Epidemiology, and Interventional Radiology.
Harmonization of the components of this dataset, including into standard DICOM representation, was supported in part by the NCI Imaging Data Commons consortium. NCI Imaging Data Commons consortium is supported by the contract number 19X037Q from Leidos Biomedical Research under Task Order HHSN26100071 from NCI.
Data Access
| Data Type | Download all or Query/Filter | License |
|---|---|---|
Images and Segmentations (DICOM, 26.6 GB) |
| |
| Clinical data with description (XLSX) |
Click the Versions tab for more info about data releases.
Additional Resources for this Dataset
The following external resources have been made available by the data submitters. These are not hosted or supported by TCIA, but may be useful to researchers utilizing this collection.
- Source code is publicly available on Github at https://github.com/fuentesdt/livermask
- Multiple open-source software can be used to visualize the DICOM-Seg files; the authors of this Collection highly recommend using the latest stable version of 3D-Slicer for data visualization after installing the “quantitative reporting” extension. Step-by-step installation and guidance can be found in: https://qiicr.gitbook.io/quantitativereporting-guide/. For the full list of the available software, please visit dcmqi documentation for instructions at: https://dicom4qi.readthedocs.io/en/latest/results/seg/
The NCI Cancer Research Data Commons (CRDC) provides access to additional data and a cloud-based data science infrastructure that connects data sets with analytics tools to allow users to share, integrate, analyze, and visualize cancer research data.
- Imaging Data Commons (IDC) (Imaging Data)
Detailed Description
Image Statistics | |
|---|---|
Modalities | CT, SEG |
Number of Patients | 105 |
Number of Studies | 214 |
Number of Series | 677 |
Number of Images | 51,968 |
| Images Size (GB) | 26.6 |
These SEG were originally created as NIfTI format files (Amira Software, ThermoFisher 2019) , and converted to DICOM.
Github link for the NN code: https://github.com/fuentesdt/livermask
Note - the mask on Patient ID HCC_001 (SEG file Series UID 1.2.276.0.7230010.3.1.3.8323329.719.1600928570.399942) has a slightly different dimension than the CT (Series UI 1.3.6.1.4.1.14519.5.2.1.1706.8374.302065206690360709343725942120) . This difference is is far from the interesting features and the masks, so clinical interpretation should be unaffected by this discrepancy.
Citations & Data Usage Policy
Data Citation
Moawad, A. W., Fuentes, D., Morshid, A., Khalaf, A. M., Elmohr, M. M., Abusaif, A., Hazle, J. D., Kaseb, A. O., Hassan, M., Mahvash, A., Szklaruk, J., Qayyom, A., & Elsayes, K. (2021). Multimodality annotated HCC cases with and without advanced imaging segmentation [Data set]. The Cancer Imaging Archive. https://doi.org/10.7937/TCIA.5FNA-0924
Publication Citation
Morshid, A., Elsayes, K. M., Khalaf, A. M., Elmohr, M. M., Yu, J., Kaseb, A. O., Hassan, M., Mahvash, A., Wang, Z., Hazle, J. D., & Fuentes, D. (2019). A Machine Learning Model to Predict Hepatocellular Carcinoma Response to Transcatheter Arterial Chemoembolization. Radiology: Artificial Intelligence, 1(5), e180021. https://doi.org/10.1148/ryai.2019180021
TCIA Citation
Clark, K., Vendt, B., Smith, K., Freymann, J., Kirby, J., Koppel, P., Moore, S., Phillips, S., Maffitt, D., Pringle, M., Tarbox, L., & Prior, F. (2013). The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository. Journal of Digital Imaging, 26(6), 1045–1057. https://doi.org/10.1007/s10278-013-9622-7
Other Publications Using This Data
TCIA maintains a list of publications which leverage TCIA data. If you have a manuscript you'd like to add please contact the TCIA Helpdesk.
- Moawad, A. W., Morshid, A., Khalaf, A. M., Elmohr, M. M., Hazle, J. D., Fuentes, D., Badawy, M., Kaseb, A. O., Hassan, M., Mahvash, A., Szklaruk, J., Qayyum, A., Abusaif, A., Bennett, W. C., Nolan, T. S., Camp, B., & Elsayes, K. M. (2023). Multimodality annotated hepatocellular carcinoma data set including pre- and post-TACE with imaging segmentation. In Scientific Data (Vol. 10, Issue 1). https://doi.org/10.1038/s41597-023-01928-3
Version 1 (Current): Updated 2022/08/17
| Data Type | Download all or Query/Filter | License |
|---|---|---|
Images and Segmentations (DICOM, 26.6 GB) | (Download requires the NBIA Data Retriever) | |
| Clinical data with description (XLSX) |